F.A.Q

Kaşkaloğlu Izmir Eye Hospital

There is no denying that Europe is home to some of the world’s finest physicians and medical institutions. However, the reality remains that not everyone can bear the steep expenses commonly associated with healthcare in Europe. Turkey stands out by providing accessible high-quality healthcare services that are affordable for all.

In several European nations, healthcare is marred by extended waiting periods and intricate bureaucracy, even for relatively minor medical procedures. The surge in medical tourism emerges as a response to these challenges, offering an alternative, so to speak. The rise of budget-friendly airlines, the widespread adoption of cutting-edge technology and equipment globally, and rapid medical advancements that lead to shorter recovery periods have all contributed to the increasing number of individuals seeking medical treatment beyond their home countries.

Kaskaloglu Eye Hospital takes care of everything, from booking your hotel room to bringing you to the clinic for your appointments to the actual surgery itself. We only team with the most experienced doctors and surgeons  to bring you the best eye care.

At Kaskaloglu Eye Hospital, our mission is to provide high-quality and affordable vision correction options. The initial consultation for any eye operation is completely free. Our basic package price for eye surgery includes post-operative eye drops, follow-up assessments, and any further laser eye surgery treatment within ten years if required. For added convenience, we also offer a Premium package, which includes the basic package along with airport-hotel-hospital transfers and a comfortable 3 or 4-star hotel stay (single or double occupancy) with breakfast for 3 nights.

Absolutely. In addition to having some of the finest medical facilities in the world, Turkey is a modern, developed country and offers a much safer, more comfortable option than some of less developed medical travel destinations.

Certainly! Add-on lenses, also known as secondary or piggyback lenses, are intraocular lenses (IOLs) implanted in the eye in addition to an existing primary IOL. They’re typically used to adjust or enhance the eye’s refractive outcome after the primary IOL has been implanted during cataract surgery.

Trifocal IOLs, on the other hand, are designed to provide clear vision at three distinct distances: near, intermediate, and distance.

Here’s a combination of both concepts — an add-on trifocal intraocular lens:

  1. Purpose: An add-on trifocal IOL is intended to provide patients with a broader range of clear vision, encompassing near, intermediate, and far distances, when the primary IOL doesn’t offer such a range or when a patient’s needs evolve over time.
  2. Design: The lens has three distinct focal points to correspond with the three main vision ranges. It’s designed to be thin and light, allowing it to be placed in front of an existing primary IOL without causing complications or crowding.
  3. Implantation: The add-on lens is usually placed in the ciliary sulcus of the eye, a space located just in front of the primary IOL, which is positioned within the capsular bag where the natural lens used to be.
  4. Advantages:

– Flexibility: If a patient’s refractive needs change over time or if the outcome of the primary IOL isn’t ideal, an add-on lens can be a less invasive option than replacing the primary IOL.

– Adjustability: In case of a refractive surprise post-cataract surgery or if presbyopia advances, an add-on lens can be implanted to correct the vision without having to explant the primary IOL.

– Reduction in Spectacle Dependence: The trifocal design aims to minimize the need for glasses across a range of distances.

  1. Considerations:

– Visual Phenomena: As with all multifocal lenses, there might be potential visual side effects, such as halos or glare, especially at night. These effects might diminish over time as the brain adapts.

– Surgical Risks: While the insertion of an add-on IOL is typically straightforward, any surgical procedure comes with potential risks, such as infection, inflammation, or retinal complications.

If you or someone you know is considering an add-on trifocal IOL, it’s essential to consult with an ophthalmologist to understand the potential benefits, risks, and suitability of the procedure.

Of course! Our doctors have experience with SML, EyeMax Mono and other telescopic intraocular laens implants. The SML (Scharioth Macula Lens) is another type of intraocular lens (IOL) specifically designed for patients with macular diseases, such as age-related macular degeneration (AMD). Here’s some information about the SML:

  1. Purpose: The SML has been developed to help patients with macular degeneration, especially those who have difficulty with central vision tasks like reading. It’s designed to provide magnification to aid in these tasks.
  2. Design: The SML features a central magnifying portion within the IOL. This central area provides a +10D (Diopter) addition, offering a magnified image of what’s directly in front of the eye, aiding the remaining healthy retinal cells in the macula to capture more detailed visual information.
  3. Implementation: Typically, the SML is implanted during cataract surgery. Once the natural, clouded lens is removed, the SML can be placed in the same capsular bag. However, for those who’ve already undergone cataract surgery with a standard IOL implant, another option would be a supplementary IOL placement where the SML is added in front of the existing IOL.
  4. Outcomes: Patients who have received the SML implant have reported improved reading abilities and better performance in tasks requiring detailed vision. However, as with any intervention, results can vary among individuals.
  5. Benefits: The primary benefit of the SML is its magnifying capability, which can assist patients with macular degeneration in tasks they find challenging, like reading or seeing detailed images.
  6. Limitations: The magnifying effect is beneficial for near tasks, but the lens does not restore vision to its pre-degeneration state or cure macular degeneration. Additionally, the magnified view is specific to the central portion of the visual field, so peripheral vision remains unaffected.

If considering the SML or any other IOL, it’s essential to consult with an ophthalmologist to discuss potential benefits, risks, and the procedure itself.

Certainly!  Our doctors have experience with EyeMax Mono, SML,and other telescopic intraocular lens implants. The EyeMax Mono intraocular lens (IOL) is a specialized lens designed for patients with macular degeneration. Macular degeneration is a progressive eye disease that affects the macula, the central part of the retina responsible for detailed, central vision. The disease leads to a loss of central vision, making everyday tasks like reading or recognizing faces difficult.

Here’s some information about the EyeMax Mono IOL:

  1. Purpose: Unlike standard IOLs, which are primarily designed to address cataracts, the EyeMax Mono is designed specifically to enhance the image quality for those with macular degeneration.
  2. Design: The EyeMax Mono is uniquely structured to maximize the use of peripheral retina. By distributing light uniformly across the entire retina (and not just the damaged macula), it can help the patient use healthier parts of the retina for better vision.
  3. Cataract Surgery: This IOL is often implanted during cataract surgery. Once the natural, clouded lens is removed during cataract surgery, the EyeMax Mono IOL is placed to not only replace the lens but also help with the vision limitations caused by macular degeneration.
  4. Outcomes: Patients who have undergone cataract surgery with the EyeMax Mono implant have reported improvement in their overall quality of vision. However, it’s essential to set realistic expectations. While the EyeMax Mono can help to improve vision, it won’t cure macular degeneration or completely restore vision to what it was before the onset of the disease.
  5. Considerations: Like all medical procedures and interventions, there are potential risks and benefits. It’s important for patients to discuss with their ophthalmologist if the EyeMax Mono IOL is right for them, considering their specific condition and needs.
  6. Limitations: While the EyeMax Mono can enhance visual outcomes in patients with macular degeneration, it is not a treatment or cure for the disease itself. Patients will still have macular degeneration after the lens is implanted.

If you or someone you know is considering the EyeMax Mono IOL, it’s vital to have a thorough discussion with an ophthalmologist to understand the potential benefits, risks, and limitations of the lens.

Age-related macular degeneration (AMD) stands as a prevalent source of visual impairment, predominantly affecting the elderly population. AMD presents in two distinctive forms: the dry type and the wet type, each having specific diagnostic criteria and treatment modalities. While abundant information is available online, this discussion is dedicated to elucidating our diagnostic procedures and therapeutic interventions.

Our ophthalmologists can detect age-related macular degeneration through meticulous examination of the eye’s posterior segment. However, for a comprehensive diagnosis, advanced imaging modalities are employed, such as Optical Coherence Tomography (OCT) and OCT-A angiography, complemented by Fundus Fluorescein Angiography (FFA). These techniques aid in differentiating between dry and wet AMD, paving the way for suitable treatment options.

For patients diagnosed with dry type AMD, we typically recommend specific multivitamin and mineral supplements aimed at preserving visual integrity. A revolutionary treatment for dry AMD is VALEDA Photobiomodulation, consisting of nine sessions, each spanning five minutes. This treatment, renowned for its safety profile, is devoid of side effects and complications, with its principal goal being to decelerate the progression of dry AMD.

It is crucial to note that 10% of dry AMD cases may evolve into the wet type. In such instances, therapeutic interventions focus on administering anti-VEGF injections, effectively inhibiting the development and maturation of new blood vessels susceptible to hemorrhage. Eylea and Lucentis are among the most prevalent medications utilized for this purpose.

At Kaskaloglu Hospital, we endeavor to enhance the visual acuity of eligible patients by implanting innovative “telescopic” intraocular lenses, such as EyeMax Mono and SML lenses. Detailed information regarding these lenses is accessible on our FAQ page. Furthermore, our extensive experience encompasses the utilization of the Implantable Miniature Telescope (IMT).

Should you find interest in exploring these advanced treatment options, we encourage you to establish contact with us. Our commitment is to provide cutting-edge, individualized care, enabling our patients to experience improved visual quality and a heightened sense of well-being.

Son Güncelleme 22 September 2023 Saat 10:57 am